Immunogen (NASDAQ:IMGN) reported its Q3 earnings results on Friday, October 29, 2021 at 06:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Immunogen reported in-line EPS of $-0.18 versus an estimate of $-0.18.
Revenue was up $8,979,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03, which was followed by a 0.71% drop in the share price the next day.
Here’s a look at Immunogen’s past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.18 | -0.19 | -0.08 | -0.18 |
| EPS Actual | -0.15 | -0.17 | 0.16 | -0.13 |
| Revenue Estimate | 18.92M | 17.73M | 40.83M | 15.36M |
| Revenue Actual | 16.95M | 15.71M | 85.80M | 18.19M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
